Amedisys, Inc. (NASDAQ:AMED) Shares Sold by Thrivent Financial for Lutherans

Thrivent Financial for Lutherans cut its holdings in shares of Amedisys, Inc. (NASDAQ:AMED) by 2.8% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 7,667 shares of the health services provider’s stock after selling 218 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Amedisys were worth $740,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Alpine Associates Management Inc. increased its position in shares of Amedisys by 0.9% during the second quarter. Alpine Associates Management Inc. now owns 1,280,897 shares of the health services provider’s stock valued at $117,586,000 after acquiring an additional 11,000 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in Amedisys by 4.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 514,166 shares of the health services provider’s stock valued at $47,202,000 after purchasing an additional 19,660 shares during the last quarter. Calamos Advisors LLC increased its holdings in Amedisys by 11.6% in the 2nd quarter. Calamos Advisors LLC now owns 397,347 shares of the health services provider’s stock valued at $36,476,000 after purchasing an additional 41,220 shares during the last quarter. Highbridge Capital Management LLC raised its position in Amedisys by 34.7% in the second quarter. Highbridge Capital Management LLC now owns 323,200 shares of the health services provider’s stock valued at $29,670,000 after purchasing an additional 83,200 shares during the period. Finally, SG Americas Securities LLC lifted its stake in Amedisys by 413.4% during the third quarter. SG Americas Securities LLC now owns 196,713 shares of the health services provider’s stock worth $18,985,000 after purchasing an additional 158,398 shares in the last quarter. 94.36% of the stock is owned by institutional investors and hedge funds.

Amedisys Trading Down 5.4 %

Shares of NASDAQ AMED opened at $86.27 on Wednesday. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.05. The stock has a market capitalization of $2.83 billion, a PE ratio of 34.23, a PEG ratio of 1.92 and a beta of 0.73. Amedisys, Inc. has a twelve month low of $85.84 and a twelve month high of $98.95. The stock has a fifty day simple moving average of $94.63 and a 200-day simple moving average of $95.59.

Amedisys (NASDAQ:AMED) last released its earnings results on Wednesday, November 6th. The health services provider reported $1.00 earnings per share for the quarter, missing the consensus estimate of $1.19 by ($0.19). The firm had revenue of $587.67 million during the quarter, compared to analyst estimates of $586.75 million. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The business’s revenue was up 5.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.98 earnings per share. On average, equities analysts forecast that Amedisys, Inc. will post 4.53 earnings per share for the current year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.